ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race against time: experimental drugs target inherited Alzheimer's before symptoms appear
Disease control OngoingThis clinical trial is testing several different drugs to see if they can slow down or prevent cognitive decline in people who carry genetic mutations that cause inherited Alzheimer's disease. The study includes 490 participants who either have early symptoms or are still symptom…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Could cleaning your teeth slow Alzheimer's?
Disease control ENROLLING_BY_INVITATIONThis study is testing whether treating severe gum disease can slow the progression of Alzheimer's disease. Researchers believe gum disease causes body-wide inflammation that may worsen Alzheimer's. The trial will enroll 70 people who have both conditions, giving half immediate gu…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New Two-Drug attack on inherited Alzheimer's aims to slow brain decline
Disease control OngoingThis trial is testing whether adding an experimental anti-tau drug (E2814) to an approved anti-amyloid drug (lecanemab) can better slow the progression of Alzheimer's disease in people who have a specific genetic mutation that causes it. It involves about 200 participants, some w…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New Alzheimer's drug aims to target brain plaques
Disease control OngoingThis study is testing a new drug called RO7126209 in people with early-stage Alzheimer's disease. The main goals are to check if the drug is safe and to see if it can reduce the amount of amyloid plaque, a key protein buildup, in the brain. The drug is given by IV infusion, and p…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Blood test aims to cut Alzheimer's diagnosis time
Diagnosis TerminatedThis study aimed to see if using a new blood test for Alzheimer's disease could help doctors reach a confident diagnosis faster. It planned to involve adults over 50 with memory concerns at Veterans Affairs and other memory clinics. Participants would have been randomly assigned …
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Diagnosis
Last updated Mar 23, 2026 15:18 UTC